Immuthera Revenue
Biotechnology Research • • 1-10 Employees
Immuthera revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Immuthera
Piotr Trzonkowski
CEO w Immuthera.bio
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Immuthera Email Formats
Immuthera uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@immuthera.bio), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@immuthera.bio | 100% |
About Immuthera
Immuthera is pioneering novel cell-based therapies for clinical development in the United States and Canada. Immuthera will be clinically developing assets initially developed by PolTREG under the US FDA regulatory framework. Immuthera will have full access to PolTREG’s Research and Development capabilities along with the ability to explore novel modalities developed by US Institutions. Immuthera is currently seeking investment to pursue the manufacture and clinical development of these assets in the United States.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Immuthera has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Immuthera has never raised funding before.
Portugal
Netherlands
United States
Lithuania
Frequently asked questions
4.8
40,000 users
